Nicole Lieber
Acute Care · Long Island City, NYNPI 1023532371
Payments from drug & device makers
Across 70 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Taiho Oncology, Inc.$148
- Regeneron Healthcare Solutions, Inc.$124
- AstraZeneca$124
- Bayer$116
- EMD Serono, Inc.$87
- Takeda Pharmaceuticals U.S.A., Inc.$78
- plus $598 from 17 others
What the payments were for
- Food & beverage$1,276100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,276 in reported general payments places this provider in the 80th percentile of 980 acute care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 20 | $163 |
| Prochlorperazine Maleate | 15 | $162 |
| Levothyroxine Sodium | 11 | $92 |
| Prednisone | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Other acute care in Long Island City
- Daniel VerinaNew York$464K
- Michele BiscossiSaratoga Springs$64K
- Heidi YipCanandaigua$29K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Ann HarrisBrooklyn$14K
- Marcel RozarioMedina$10K
- Julie Anne RoldanNew York$10K
- Dana SiscoSuffern$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.